Keyphrases
Systemic Lupus Erythematosus
100%
Rheumatoid Arthritis
32%
Behçet's Disease
25%
TREM-1
23%
Antiphospholipid Syndrome
19%
Neutrophils
19%
Disease Activity
18%
Lupus
18%
L-selectin
16%
Israeli
16%
Systemic Lupus Erythematosus Patient
15%
Tocilizumab
14%
Autoantibodies
13%
Israel
13%
Lupus Anticoagulant
12%
SLE Disease Activity Index (SLEDAI)
12%
Disease Activity Score
12%
Clinical Manifestations
11%
Clinical Features
11%
Disease-modifying Antirheumatic Drugs (DMARDs)
11%
Vascular Morbidity
10%
Methotrexate
10%
All-cause Mortality
10%
Integrin
10%
Scleroderma
9%
Antiphospholipid Antibodies
9%
Surface Expression
9%
Neutrophil Activation
9%
Disease Manifestations
9%
Neutrophil Adhesion
9%
Rheumatoid Arthritis Patients
9%
HLA-B5
9%
Chronic Kidney Disease
9%
Adverse Events
8%
Lupus Nephritis
8%
American College of Rheumatology
8%
Hydroxychloroquine
8%
Disease Severity
8%
Subcutaneous Injection
8%
Lupus Pregnancy
8%
Anti-Ro
8%
Congenital Heart Block
8%
CD18
8%
Disease Expression
8%
Renal Outcome
8%
Glycoprotein
7%
Macrophages
7%
Damage Index
7%
Chemoattractant
7%
Autoimmune Disease
7%
Medicine and Dentistry
Systemic Lupus Erythematosus
78%
Disease
40%
Lupus Erythematosus
29%
Behcet Disease
21%
Rheumatoid Arthritis
19%
Antiphospholipid Syndrome
18%
Disease Activity
16%
Vasculitis
14%
Glycoprotein
13%
Lupus Anticoagulant
12%
Triggering Receptor Expressed on Myeloid Cells 1
10%
Antiphospholipid Antibody
10%
Mitogen-Activated Protein Kinase
10%
Chronic Kidney Disease
9%
All Cause Mortality
9%
Cancer
9%
SLEDAI
8%
Disease Modifying Antirheumatic Drug
8%
Cohort Analysis
8%
Hydroxychloroquine
8%
Rheumatology
8%
Tocilizumab
7%
Rheumatic Disease
7%
Cross Sectional Study
7%
Systemic Disease
7%
Subcutaneous Injection
7%
Biological Marker
7%
Antisynthetase Syndrome
7%
Thrombosis
7%
Autoantibodies
6%
Adverse Event
6%
Neutrophil
6%
Biological Product
6%
Leukocyte Activation
6%
Clinical Feature
5%
Macrophage
5%
Cell Adhesion Molecule
5%
Programmed Cell Death
5%
Immunology and Microbiology
Systemic Lupus Erythematosus
61%
Lupus Erythematosus
37%
Behcet Disease
21%
Myeloid
21%
L-Selectin
17%
Neutrophil
15%
Integrin
13%
Neutrophil Granulocyte
12%
Inflammatory Arthritis
12%
Antiphospholipid Syndrome
12%
Autoantibodies
11%
Blood Level
10%
Monospecific Antibody
9%
Surface Property
9%
Vasculitis
9%
Phospholipid Antibody
9%
All Cause Mortality
8%
Macrophage
8%
Chemoattractant
8%
CD18
8%
Leukocyte Activation
7%
Systemic Scleroderma
7%
Cell Adhesion Molecule
7%
Ro Antibody
7%
Nephritis
7%
Cytokine
6%
Upregulation
6%
Blood Plasma
6%
Disease-Modifying Antirheumatic Drug
5%
Comorbidity
5%
Tumor Necrosis Factor
5%
Scleroderma
5%
Glycoprotein
5%
Autoimmune Disease
5%
Methotrexate
5%
Hydroxychloroquine
5%
Antiinflammatory Activity
5%
Rituximab
5%